Peritoneal dissemination of pancreatic cancer caused by endoscopic ultrasound-guided fine needle aspiration: A case report and literature review

Table 1 Clinical features of 24 previous cases of dissemination after endoscopic ultrasound-guided fine needle aspiration

No	Author [ref.], year	Primary lesion					EUS-FNA		Recurrence
		Diagnosis	size, mm	Location	Initial therapy	Cystic lesion	Puncture site	Passes, n		Interval from EUS-FNA, mo	Location	size, mm	Treatment	Outcomes
1	Hirooka et al[12], 2003	IPMC	20	Pb	DP+LG	(+)	Trans-gastric			0	G/Wserosa	7		Died 25 mo after surgery
2	Paquin et al[13], 2005	IPMC	8	Pt	DP	(+)	Trans-gastric	5		21	G/W	30	Palliative Chemotherapy	Died 12 mo after diagnosis
3	Ahmed et al[14], 2011	PDAC		Pb	MPAdj gefinitiveRadiation	(+)	Trans-gastric	multiple		48	G/W	45	TG	Died of another malignancy
4	Chong et al[15], 2011	IDC	28	Pt	DP	(+)	Trans-gastric	2		26	G/W	40
5	Katanuma et al[16], 2012	IDC	20	Pb	DP	(-)	Trans-gastric	4		22	G/W
6	Ngamruengphong et al[9], 2013	IDC		Pb, Pt	Subtotal PancreatomyRadiation	(+)	Trans-gastric	3		27	G/W
7	Ngamruengphong et al[9], 2013	IDC	40	Pt	DP+LGAdj Chemoradiation	(+)	Trans-gastric	3		26	G/W
8	Sakurada et al[17], 2015	Adeno-squamous	25	Pb	DP	(-)	Trans-gastric			19	G/W	20	LG	No recurrence after 16 mo follow-up
9	Tomonari et al[18], 2015	IDC	20	Pb	DPAdj S-1	(-)	Trans-gastric	2		28	G/W	32	Subtotal Gastrectomy
10	Minaga et al[19], 2015	IDC	20	Pt	DP	(-)	Trans-gastric	3		8	G/W	12	LG
11	Hirohito et al[20], 2015	IDC	20	Pb	GEM⇒S-1	(-)	Trans-gastric	4		9	G/W	16	Palliative Chemotherapy	Died 11 mo after diagnosis
12	Yamauchi et al[21], 2016	IDC	25	Pb	DP	(-)	Trans-gastric	1		23	G/W	30	LG
13	Iida et al[22], 2016	IDC			DP	(-)	Trans-gastric	3		6	G/W	18	DGAdj S-1	Recurrence after 21 mo follow-up
14	Kita et al[23], 2016	IDC		Pb, Pt	Radiation	(-)	Trans-gastric	2		7	G/W
15	Minaga et al[24], 2016	IDC	10	Pb	DP	(-)	Trans-gastric			24	G/W	30
16	Yamabe et al[25], 2016	IPMC	30	Pb	GEM	(+)	Trans-gastric			3	G/W	24	Palliative Chemotherapy	Died 26 months after diagnosis
17	Yasumoto et al[26], 2018	IDC	10	Pb	DPAdj S-1	(-)	Trans-gastric			22	G/W		LG
19	Sakamoto et al[27], 2018	IDC	38	Pt	DPAdj S-1+Gem	(-)	Trans-gastric	2		24	G/W	20	LG
18	Matsumoto et al[28], 2018	IDC	25	Pb	Chemotherapy	(-)	Trans-gastric	3		8	G/W		DP+LG
20	Matsui et al[29], 2019	IDC	15	Pb	DPPartial Gx	(-)	Trans-gastric	4		0	G/Wserosa		Adj S-1	Recurrence 6 mo after surgery; Died 18 mo after surgery
21	Matsui et al[29], 2019	IDC	15	Pb	DP+LG	(-)	Trans-gastric	1		0	G/Wserosa		Adj S-1	No recurrence after 18 mo follow-up
22	Sato et al[30], 2020	IDC	25	Pb	DPAdj S-1	(-)	Trans-gastric	2		25	G/W	23	LG	No recurrence after 5 mo follow-up
23	Yamaguchi et al[31], 2020	SPN	60	Pb	DP	(+)	Trans-gastric	4		60	G/W	40	DG
24	Current case	IDC	16	Pb	DP	(-)	Trans-gastric	4		0	Peritoneum			Cancerous peritonitis and liver metastasis 5 mo after surgeryDied 8 mo after surgery

EUS-FNA: Endoscopic ultrasound-guided fine needle aspiration; IDC: Invasive ductal carcinoma; IPMC: Intraductal papillary mucinous carcinoma; SPN: Solid-pseudopapillary neoplasm; Pb: Pancreatic body; Pt: Pancreatic tail; DP: Distal pancreatectomy; MP: Middle pancreatectomy; LG: Local gastrectomy; DG: Distal gastrectomy; TG: Total gastrectomy; Adj: Adjuvant; S-1: Tegafur, gineracil, oteracil potassium; GEM: Gemcitabine hydrochloride; G/W: Gastric wall.